Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > CT Providers

Dr. Sherwin Ignatius Desouza, MD

(No ratings)

Specializes in: Adult Oncology and Adult Hematology

St. John's Medical College

Professional interests include: anemia, neutropenia, thrombocytopenia (low platelet count)

8326 Naab Road
Indianapolis, IN 46260

(317) 871-0011

Dr. Sherwin Ignatius Desouza, MD is an oncologist in Bridgeport, CT specializing in adult oncology and adult hematology. He graduated from St. John's Medical College. Dr. Sherwin Ignatius Desouza, MD is affiliated with Innovative Hematology, Inc..

Office Locations

267 Grant Street
Bridgeport, CT 06610

(203) 384-3000

open_in_new

6845 Rama Drive
Indianapolis, IN 46219

(317) 948-1900

open_in_new

8326 Naab Road
Indianapolis, IN 46260

(317) 871-0011

(317) 870-4552

open_in_new

Some issues Dr. Sherwin Ignatius Desouza, MD can help you with:

Anemia

Anemia is the most common blood disorder. It occurs when the body does not have enough red blood cells to carry oxygen to the tissues. Blood loss, insufficient red blood cell production, and red blood cell destruction are the three main causes of anemia. These issues may arise from such conditions as iron deficiency, heavy periods, ulcers, kidney disease, as well as some forms of cancer.

An individual with anemia will have the following symptoms: shortness of breath, weakness, dizziness, cold hands or feet, paleness, and irritability. Anemia is diagnosed when blood tests show low counts for hemoglobin, which is the protein responsible for carrying oxygen to different tissues throughout the body.

Treatments for anemia are dependent on the kind of anemia an individual has. For example, iron supplementation may correct iron deficiency anemia. For anemia caused by chronic kidney failure, chemotherapy treatments, and HIV/AIDS, a group of medications called erythropoiesis-stimulating agents may be prescribed.

Thrombocytopenia (Low Platelet Count)

Thrombocytopenia is a disorder where people have too few platelets. With too few platelets in the bloodstream, the blood is unable to properly clot. People with thrombocytopenia may experience prolonged external and internal bleeding. Large purple bruises (ecchymoses) and small red skin spots (petechiae) in the skin and mouth are common in those with thrombocytopenia. Other symptoms of the disorder include bleeding gums, blood in bodily fluids, and fatigue. Thrombocytopenia most often arises from a different condition or treatment, such as alcoholism, autoimmune disease, cancer treatments, viruses (such as Hepatitis C and HIV), bone marrow diseases (such as leukemia and aplastic anemia), enlarged spleen, and exposure to toxic chemicals. In rare cases, thrombocytopenia is inherited.

If a doctor suspects a patient has a thrombocytopenia, a complete blood count (CBC) or platelet count test helps determine the concentration of platelets in a person's blood at a given time. Thrombocytopenia can be diagnosed by hematologists using advanced tests on platelet samples. Flow cytometry tests detect abnormalities by evaluating the characteristics of a platelet sample using targeted lasers and lights.

Treatments for low platelet counts include steroids like Prednisone, that can assist with platelet production. If a patient's low platelet count is caused by spleen problems, spleen removal (splenectomy) may be recommended. To treat the prolonged bleeding caused by thrombocytopenia, doctors frequently prescribe Dempressin, a hormone that promotes blood clotting. Antifibrinolytic medications such as tranexamic acid may also aid in the promotion of clotting and the prevention of bleeding. For patients with severe platelet disorders (either low platelet count and dysfunctional platelets), blood transfusions may be prescribed. Platelet blood transfusions deliver donated platelets to patients intravenously, replenishing the volume of functioning platelets.

Patients can also modify their lifestyle to better manage their disorder and minimize complications. Patients with low blood counts should avoid blood-thinning medications, alcohol, and activities that could lead to injury. Many people with thrombocytopenia can live healthy and fulfilling lives with proper treatment and precautions.

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Sherwin Ignatius Desouza, MD treated as an oncologist in Bridgeport, CT during 2021 were hospital care and inpatient care.

Volume of procedures performed by Dr. Sherwin Ignatius Desouza, MD for Medicare patients.

hospital care	14
inpatient care	14

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Sherwin Ignatius Desouza, MD.

**Gender**
Male	16
Female	17

**Ethnicity**
Non-Hispanic White	16
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	14
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Sherwin Ignatius Desouza, MD in 2021

Hypertension	75
High Cholesterol	61
Stroke	0
Ischemic Heart Disease	52
Depression	42
Chronic Kidney Disease	67
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	45
Chronic Obstructive Pulmonary Disease	0
Diabetes	36
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Sherwin Ignatius Desouza, MD treated as an oncologist in Bridgeport, CT during 2022 were hospital care and inpatient care.

Volume of procedures performed by Dr. Sherwin Ignatius Desouza, MD for Medicare patients.

doctor visit	145
hospital care	61
inpatient care	61

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Sherwin Ignatius Desouza, MD.

**Gender**
Male	41
Female	71

**Ethnicity**
Non-Hispanic White	57
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	44
From 75 to 84	35
85 and over	17
Less than 65	16

Conditions of Medicare patients treated by Dr. Sherwin Ignatius Desouza, MD in 2022

Hypertension	75
High Cholesterol	72
Stroke	13
Ischemic Heart Disease	31
Depression	28
Chronic Kidney Disease	37
Asthma	16
Osteoperosis	15
Atrial Fibrilation	21
Heart Failure	27
Chronic Obstructive Pulmonary Disease	25
Diabetes	36
Dementia	0
Cancer	23

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2021 - 2022

Volume of procedures performed by Dr. Sherwin Ignatius Desouza, MD for Medicare patients.

The highest averages for the top procedures that Dr. Sherwin Ignatius Desouza, MD treated as an oncologist in Bridgeport, CT were hospital care and inpatient care.

doctor visit	145
hospital care	37
inpatient care	37

Average Medicare Patient Data From 2021 - 2022

Information about Medicare patients treated by Dr. Sherwin Ignatius Desouza, MD.

**Gender**
Male	28
Female	44

**Ethnicity**
Black / African American	0
Asian / Pacific Islander	0
Non-Hispanic White	36
Native American / Alaskan Native	0
Hispanic	0
Other	0

**Age**
75 to 84	17
85 and over	8
Less than 65	8
65 to 74	29

Average of Total of Conditions of Medicare patients treated by Dr. Sherwin Ignatius Desouza, MD From 2021 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. Sherwin Ignatius Desouza, MD treated were hypertension, high cholesterol, chronic kidney disease and diabetes.

Hypertension	75
High Cholesterol	66
Stroke	6
Ischemic Heart Disease	41
Depression	35
Chronic Kidney Disease	52
Asthma	8
Osteoporosis	7
Heart Failure	36
Chronic Obstructive Pulmonary Disease	12
Diabetes	36
Atrial Fibrillation	10
Dementia	0
Cancer	11

Education & Training

Dr. Sherwin Ignatius Desouza, MD graduated from St. John's Medical College. He completed residency at Bridgeport Hospital. He has a state license in Connecticut.

Medical School: St. John's Medical College

Residency: Bridgeport Hospital

Licensed In: Connecticut

Affiliations & Hospitals

Dr. Sherwin Ignatius Desouza, MD is associated with these hospitals and organizations:

Innovative Hematology, Inc.

Ratings & Reviews

Dr. Sherwin Ignatius Desouza, MD does not have any reviews yet, be the first to leave a review of Dr. Sherwin Ignatius Desouza, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Sherwin Ignatius Desouza, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
GENZYME CORPORATION	$138 CABLIVI $116	ENJAYMO $22
Genmab U.S., Inc.	$44 TIVDAK $44
Astellas Pharma US Inc	$34 XOSPATA $34
Amgen Inc.	$24 XGEVA $24
Merck Sharp & Dohme LLC	$22 KEYTRUDA $22
Other	$113 Lenvima $22	JAKAFI $20	ULTOMIRIS $20	TECENTRIQ $19	BRUKINSA $18	Other $14

**Types of Payments**
Food and Beverage	$374

Research Payments

Dr. Sherwin Ignatius Desouza, MD has received 1 research payments totaling $245.

Biography

Dr. Sherwin Desouza is a specialist in adult hematology and adult oncology. Before performing his residency at Bridgeport Hospital, Dr. Desouza attended St. John's Medical College for medical school. In Dr. Desouza's practice, he is particularly interested in anemia, neutropenia, and thrombocytopenia (low platelet count). He is professionally affiliated with Innovative Hematology, Inc..